T-Cell Therapies Offer New Ways to Treat Lung Cancer - Cure Today
T-Cell Therapies Offer New Ways to Treat Lung Cancer Cure Today
🎗️
Онкология
Рак лёгких
277 материалов по теме, собраны автоматически из проверенных источников
Онкология
Pancreatic Cancer Drug Shows Early Promise For Lung Cancer Patients - 1310 WIBA - Madison's News/Talk Station
Pancreatic Cancer Drug Shows Early Promise For Lung Cancer Patients 1310 WIBA - Madison's News/Talk Station
Онкология
Pancreatic cancer drug may hold promise for lung cancer as well, early study suggests - ABC News - Breaking News, Latest News and Videos
Pancreatic cancer drug may hold promise for lung cancer as well, early study suggests ABC News - Breaking News, Latest News and Videos
Онкология
Daraxonrasib ‘encouraging’ in RAS-mutant metastatic lung cancer
An oral drug widely expected to transform pancreatic cancer treatment has demonstrated encouraging clinical activity in metastatic non-small cell lung cancer. Daraxonrasib (Rasonque, Revolution Medicines) induced durable responses in patients with previously treated, RAS-mutant NSCLC, according to results of a phase…
Онкология
Akeso drug shows survival benefit in lung cancer trial - China Daily Global Edition
Akeso drug shows survival benefit in lung cancer trial China Daily Global Edition
Онкология
An experimental lung cancer drug held disease in check for 89% of patients in one group. - Stock Titan
An experimental lung cancer drug held disease in check for 89% of patients in one group. Stock Titan
Онкология
Daraxonrasib demonstrates initial antitumor activity in RAS-mutant lung cancer - UT MD Anderson
Daraxonrasib demonstrates initial antitumor activity in RAS-mutant lung cancer UT MD Anderson
Онкология
Newly approved pancreatic cancer drug shows promise in lung cancer - NBC News
Newly approved pancreatic cancer drug shows promise in lung cancer NBC News
Онкология
Daraxonrasib demonstrates initial antitumor activity in RAS-mutant lung cancer
Daraxonrasib, an oral RAS inhibitor therapy, achieved durable responses in pretreated patients with RAS-mutant non-small cell lung cancer (NSCLC) in a phase 1/2 trial led by The University of Texas MD Anderson Cancer Center.
Онкология
Рак легких может долго протекать незаметно: онколог назвал тревожные признаки - Новости Zakon.kz
Рак легких может долго протекать незаметно: онколог назвал тревожные признаки Новости Zakon.kz
Онкология
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - Yahoo! Finance Canada
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer Yahoo! Finance Canada
Онкология
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer - PR Newswire
Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer PR Newswire
Онкология
Large language model-based system identifies cardiac event data in cancer patients' electronic health records
Patients with breast and lung cancer are at increased risk of cardiotoxicity, or heart-related damage caused by cancer treatments, because of the proximity of the heart, lungs and breasts. Cardiotoxicity increases the risk of heart attacks, heart failure and other cardiac conditions. Looking for evidence of cardiac…
🎗️
Онкология
Potential New Treatment for Lung Cancer: Daraxonrasib Aimed at RAS Mutations - Memorial Sloan Kettering Cancer Center
Potential New Treatment for Lung Cancer: Daraxonrasib Aimed at RAS Mutations Memorial Sloan Kettering Cancer Center
Онкология
Q&A: Combining diagnosis, staging, tumor localization and surgery into a minimally invasive procedure for lung cancer
For patients with early-stage lung cancer, the journey from diagnosis to treatment often involves multiple procedures spread across several weeks or even months. During that time, patients may undergo separate biopsies to confirm a diagnosis, additional tests to determine whether the cancer has spread, procedures to…